AUTOIMMUNE DISEASES AND THYROID DYSFUNCTION IN RHEUMATOID ARTHRITIS
https://doi.org/10.14412/1995-4484-2017-211-217
Abstract
The literature review deals with various aspects of the concurrence of rheumatoid arthritis (RA) and autoimmune thyroid diseases (Hashimoto's thyroiditis and Graves' disease). It discusses the prevalence, genetic predisposition, similarity of pathogenesis and clinical symptoms, as well as the ability of organ-specific autoantibodies (anti-thyroid peroxidase antibodies, anti-thyroglobulin antibodies) and hypothyroidism to affect the course of RA and the risk of cardiovascular complications.
About the Authors
L. V. Kondratyeva
V.A. Nasonova Research Institute of Rheumatology, Moscow
Russian Federation
Russian Federation
T. V. Popkova
V.A. Nasonova Research Institute of Rheumatology, Moscow
Russian Federation
Russian Federation
References
1. Насонов ЕЛ, редактор. Ревматология. Клинические рекомендации. Москва: ГЭОТАР-Медиа; 2010 [Nasonov EL, editor. Revmatologiya. Klinicheskie rekomendatsii [Rheumatology. Clinical guidelines]. Moscow: GEOTAR-Media; 2010].
2. Александрова ЕН, Авдеева АС, Лукина ГВ и др. Клинико- иммунологические эффекты анти-В-клеточной терапии у больных ревматоидным артритом. Научно-практическая ревматология. 2012;50(1):14-21. [Aleksandrova EN, Avdeyeva AS, Lukina GV, et al. The clinical and immunological effects of anti-B-cell therapy in patients with rheumatoid arthritis. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2012;50(1):14-21 (In Russ.)]. doi: 10.14412/1995- 4484-2012-498
3. Авдеева АС, Новиков АА, Александрова ЕН и др. Связь уровней цитокинов с активностью заболевания, уровнем аутоантител и деструктивными изменениями суставов при раннем ревматоидном артрите. Научно-практическая ревматология. 2015;53(4):385-90. [Avdeeva AA, Novikov AA, Aleksandrova EN, et al. An association of cytokine levels with disease activity, autoantibody levels, and joint destructive changes in early rheumatoid arthritis. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2015;53(4):385-90 (In Russ.)]. doi: 10.14412/1995-4484-2015-385-390
4. Duraes C, Moreira CS, Alvelos I, et al. Genetic susceptibility to autoimmune thyroid disease: past, present, and future. Thyroid. 2010 Jul;20(7):715-25. doi: 10.1089/thy.2010.1644
5. Barton A, Worthington J. Genetic susceptibility to rheumatoid arthritis: an emerging picture. Arthritis Rheum. 2009 Oct 15;61(10):1441-6. doi: 10.1002/art.24672
6. Tomer Y, Huber A. The etiology of autoimmune thyroid disease: a story of genes and environment. J Autoimmun. 2009 MayJun;32(3-4):231-9. doi: 10.1016/j.jaut.2009.02.007
7. Kä llberg H, Ding B, Padyukov L, et al. EIRA Study Group. Smoking is a major preventable risk factor for rheumatoid arthritis: estimations of risks after various exposures to cigarette smoke. Ann Rheum Dis. 2011 Mar;70(3):508-11. doi: 10.1136/ard.2009.120899
8. Dayan CM, Daniels GH. Chronic autoimmune thyroiditis. N Engl J Med. 1996 Jul 11;335(2):99-107. doi: 10.1056/NEJM199607113350206
9. Ngo ST, Steyn FJ, McCombe PA. Gender differences in autoimmune disease. Front Neuroendocrinol. 2014 Aug;35(3):347-69. doi: 10.1016/j.yfrne.2014.04.004
10. Heuer M, Aust G, Ode-Hakim S, Scherbaum WA. Different cytokine mRNA profiles in Graves' disease, Hashimoto's thyroiditis, and nonautoimmune thyroid disorders determined by quantitative reverse transcriptase polymerase chain reaction (RT-PCR). Thyroid. 1996 Apr;6(2):97-106. doi: 10.1089/thy.1996.6.97
11. Nanba T, Watanabe M, Inoue N, Iwatani Y. Increases of the Th1/Th2 cell ratio in severe Hashimoto's disease and in the proportion of Th17 cells in intractable Graves' disease. Thyroid. 2009 May;19(5):495-501. doi: 10.1089/thy.2008.0423
12. Giordano C, Richiusa P, Bagnasco M, et al. Differential regulation of Fas-mediated apoptosis in both thyrocyte and lymphocyte cellular compartments correlates with opposite phenotypic manifestations of autoimmune thyroid disease. Thyroid. 2001 Mar;11(3):233-44. doi: 10.1089/105072501750159615
13. Ajjan RA, Watson PF, McIntosh RS, Weetman AP. Intrathyroidal cytokine gene expression in Hashimoto's thyroiditis. Clin Exp Immunol. 1996 Sep;105(3):523-8. doi: 10.1046/j.1365- 2249.1996.d01-784.x
14. Gianoukakis AG, Khadavi N, Smith TJ. Cytokines, Graves' disease, and thyroid-associated ophthalmopathy. Thyroid. 2008 Sep;18(9):953-8. doi: 10.1089/thy.2007.0405
15. Helen Kemp E, Ajjan RA, Metcalfe RA, et al. IL-14 and IL-16 are expressed in the thyroid of patients with either Graves' disease or Hashimoto's thyroiditis. Clin Endocrinol (Oxford). 2015 May 4. doi: 10.1111/cen.12810
16. Ajjan RA, Weetman AP. Cytokines in thyroid autoimmunity. Autoimmunity. 2003 Sep-Nov;36(6-7):351-9. doi: 10.1080/08916930310001603046
17. Mikos H, Mikos M, Obara-Moszynska M, Niedziela M. The role of the immune system and cytokines involved in the pathogenesis of autoimmune thyroid disease (AITD). Endokrynol Pol. 2014;65(2):150-5. doi: 10.5603/EP.2014.0021
18. Segni M, Pucarelli I, Truglia S, et al. High prevalence of antinuclear antibodies in children with thyroid autoimmunity. J Immunol Res. 2014;2014:150239. doi: 0.1155/2014/150239
19. Tagoe CE, Zezon A, Khattri S, Castellanos P. Rheumatic manifestations of euthyroid, anti-thyroid antibody-positive patients. Rheumatol Int. 2013 Jul;33(7):1745-52. doi: 10.1007/s00296-012- 2616-9
20. Tektonidou MG, Anapliotou M, Vlachoyiannopoulos P, Moutsopoulos HM. Presence of systemic autoimmune disorders in patients with autoimmune thyroid diseases. Ann Rheum Dis. 2004 Sep;63(9):1159-61. doi: 10.1136/ard.2004.022624
21. Perez-Moreiras JV, Alvarez-Lopez A, Gomez EC. Treatment of active corticosteroid-resistant Graves' orbitopathy. Ophthal Plast Reconstr Surg. 2014 Mar-Apr;30(2):162-7. doi: 10.1097/IOP.0000000000000037
22. Salvi M. Immunotherapy for Graves' ophthalmopathy. Curr Opin Endocrinol Diabetes Obes. 2014 Oct;21(5):409-14. doi: 10.1097/MED.0000000000000097
23. Figueroa-Vega N, Alfonso-Perez M, Benedicto I, et al. Increased circulating pro-inflammatory cytokines and Th17 lymphocytes in Hashimoto's thyroiditis. J Clin Endocrinol Metab. 2010 Feb;95(2):953-62. doi: 10.1210/jc.2009-1719
24. Ruggeri RM, Saitta S, Cristani M, et al. Serum interleukin-23 (IL-23) is increased in Hashimoto's thyroiditis. Endocr J. 2014;61(4):359-63. doi: 10.1507/endocrj.EJ13-0484
25. Насонов ЕЛ, Александрова ЕН, Новиков АА. Аутоиммунные ревматические заболевания: итоги и перспективы научных исследований. Научно-практическая ревматология. 2015;53(3):230-7 [Nasonov EL, Aleksandrova EN, Novikov AA. Autoimmune rheumatic diseases: Results and prospects for researches. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2013;53(3):230-7 (In Russ.)]. doi: 10.14412/1995-4484-2015-230-237
26. Nakano A, Watanabe M, Iida T, et al. Apoptosis-induced decrease of intrathyroidal CD4(+)CD25(+) regulatory T cells in autoimmune thyroid diseases. Thyroid. 2007 Jan;17(1):25-31. doi: 10.1089/thy.2006.0231
27. Vanderpump MPJ, Tunbridge WMG, French JM, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham survey. Clin Endocrinol. 1995;43(1):55- 68. doi: 10.1111/j.1365-2265.1995.tb01894.x
28. Cardenas Roldan J, Amaya-Amaya J, Castellanos-de la Hoz J, et al. Autoimmune thyroid disease in rheumatoid arthritis: a global perspective. Arthritis. 2012;2012:864907. doi: 10.1155/2012/864907
29. Atzeni F, Doria A, Ghirardello A, et al. Anti-thyroid antibodies and thyroid dysfunction in rheumatoid arthritis: prevalence and clinical value. Autoimmunity. 2008 Feb;41(1):111-5. doi: 10.1080/08916930701620100
30. El-Sherif WT, El Gendi SS, Ashmawy MM, et al. Thyroid disorders and autoantibodies in systemic lupus erythematosus and rheumatoid arthritis patients. Egypt J Immunol. 2004;11(2):81-90.
31. Przygodzka M, Filipowicz-Sosnowska A. Prevalence of thyroid diseases and antithyroid antibodies in women with rheumatoid arthritis. Pol Arch Med Wewn. 2009 Jan-Feb;119(1-2):39-43.
32. Raterman HG, Jamnitski A, Lems WF, et al. Improvement of thyroid function in hypothyroid patients with rheumatoid arthritis after 6 months of adalimumab treatment: a pilot study. J Rheumatol. 2011 Feb;38(2):247-51. doi: 10.3899/jrheum.100488
33. Pan XF, Gu JQ, Shan ZY. Increased risk of thyroid autoimmunity in rheumatoid arthritis: a systematic review and metaanalysis. Endocrine. 2015 Sep;50(1):79-86. doi: 10.1007/s12020- 015-0533-x
34. Shiroky JB, Cohen M, Ballachey ML, Neville C. Thyroid dysfunction in rheumatoid arthritis: a controlled prospective survey. Ann Rheum Dis. 1993 Jun;52(6):454-6. doi: 10.1136/ard.52.6.454
35. McCoy SS, Crowson CS, Gabriel SE, Matteson EL. Hypothyroidism as a risk factor for development of cardiovascular disease in patients with rheumatoid arthritis. J Rheumatol. 2012 May;39(5):954-8. doi: 10.3899/jrheum.111076
36. Парамонова ОВ, Русанова ОА, Гонтарь ИП. Взаимосвязь органоспецифической аутоиммунной патологии щитовидной железы с неорганическими аутоиммунными ревматическими заболеваниями. Клиническая и экспериментальная тиреоидология. 2012;8(1):46-50 [Paramonova OV, Rusanova OA, Gontar IP. Interrelation specific autoimmune pathologies of a thyroid gland with inorganic autoimmune rheumatic diseases. Klinicheskaya i Eksperimental'naya Tireoidologiya = Clinical and Experimental Thyroidology. 2012;8(1):46-50 (In Russ.)]. doi: 10.14341/ket20128146-50
37. Delamere JP, Scott DL, Felix-Davies DD. Thyroid dysfunction and rheumatic diseases. J R Soc Med. 1982 Feb;75(2):102-6.
38. Boelaert K, Newby PR, Simmonds MJ, et al. Prevalence and relative risk of other autoimmune diseases in subjects with autoimmune thyroid disease. Am J Med. 2010 Feb;123(2):183.e1-9. doi: 10.1016/j.amjmed.2009.06.030
39. Andonopoulos AP, Siambi V, Makri M, et al. Thyroid function and immune profile in rheumatoid arthritis. A controlled study. Clin Rheumatol. 1996 Nov;15(6):599-603. doi: 10.1007/BF02238551
40. Chan AT, Al-Saffar Z, Bucknall RC. Thyroid disease in systemic lupus erythematosus and rheumatoid arthritis. Rheumatology (Oxford). 2001 Mar;40(3):353-4. doi: 10.1093/rheumatology/40.3.353
41. Al-Awadhi AM, Olusi S, Hasan EA, Abdullah A. Frequency of abnormal thyroid function tests in Kuwaiti Arabs with autoimmune diseases. Med Princ Pract. 2008;17(1):61-5. doi: 10.1159/000109592
42. Raterman HG, van Halm VP, Voskuyl AE, et al. Rheumatoid arthritis is associated with a high prevalence of hypothyroidism that amplifies its cardiovascular risk. Ann Rheum Dis. 2008 Feb;67(2):229-32. doi: 10.1136/ard.2006.068130
43. Santos MJ, Vinagre F, Silva JJ, et al. Cardiovascular risk profile in systemic lupus erythematosus and rheumatoid arthritis: a comparative study of female patients. Acta Reumatol Port. 2010 JulSep;35(3):325-32.
44. Kerola AM, Nieminen TV, Kauppi MJ, et al. Increased risk of levothyroxine-treated hypothyroidism preceding the diagnosis of rheumatoid arthritis: a nationwide registry study. Clin Exp Rheumatol. 2014 Jul-Aug;32(4):455-9.
45. Bengtsson C, Padyukov L, Kä llberg H, Saevarsdottir S. Thyroxin substitution and the risk of developing rheumatoid arthritis; results from the Swedish population-based EIRA study. Ann Rheum Dis. 2014 Jun;73(6):1096-100. doi: 10.1136/annrheumdis-2013-203354
46. Никитина НМ, Афанасьев ИА, Романова ТА, Ребров АП. Особенности коморбидности у больных ревматоидным артритом в разные годы наблюдения. Современная ревматология. 2015;9(1):39-43. [Nikitina NM, Afanasyev IA, Romanova TA, Rebrov AP. Specific features of comorbidity in rheumatoid arthritis patients in different follow-up years. Sovremennaya Revmatologiya = Modern Rheumatology Journal. 2015;9(1):39-43 (In Russ.)]. doi: 10/14412/1996-7012-2015-1- 39-43
47. LeRiche NGH, Bell DA. Hashimoto's thyroiditis and polyarthritis: a possible subset of seronegative polyarthritis. Ann Rheum Dis. 1984 Aug;43(4):594-8. doi: 10.1136/ard.43.4.594
48. Punzi L, Michelotto M, Pianon M, et al. Clinical, laboratory and immunogenetic aspects of arthritis associated with chronic lymphocytic thyroiditis. Clin Exp Rheumatol. 1997 JulAug;15(4):373-80.
49. Blake DR, McGregor AM, Stansfield E, Smith BR. Antithyroidantibody activity in the snyovial fluid of patients with various arthritides. Lancet. 1979 Aug 4;2(8136):224-6. doi: 10.1016/S0140-6736(79)90238-1
50. Punzi L, Schiavon F, Ramonda R, et al. Anti-thyroid microsomal antibody in synovial fluid as a revealing feature of seronegative autoimmune thyroiditis. Clin Rheumatol. 1991 Jun;10(2):181-3. doi: 10.1007/BF02207661
51. Bourji K, Gatto M, Cozzi F, et al. Rheumatic and autoimmune thyroid disorders: a causal or casual relationship? Autoimmun Rev. 2015 Jan;14(1):57-63. doi: 10.1016/j.autrev.2014.10.007
52. Hezarkhani S, Sedighi S, Aghaei M, et al. Rheumatologic manifestations in Iranian patients with autoimmune thyroid diseases. J Clin Diagn Res. 2014 Oct;8(10):MC06-8. doi: 10.7860/JCDR/2014/7974.4981
53. Punzi L, Sfriso P, Pianon M, et al. Clinical manifestations and outcome of polyarthralgia associated with chronic lymphocytic thyroiditis. Semin Arthritis Rheum. 2002 Aug;32(1):51-5. doi: 10.1053/sarh.2002.33722
54. Ahmad J, Blumen H, Tagoe CE. Association of antithyroid peroxidase antibody with fibromyalgia in rheumatoid arthritis. Rheumatol Int. 2015 Aug;35(8):1415-21. doi: 10.1007/s00296-015-3278-1
55. Серебряков ВГ, Алекберова ЗС, Корешков ГГ, Зеновко ЕИ. Особенности течения ревматоидного артрита, сочетающегося с патологией щитовидной железы. Терапевтический архив. 1990;62(5):48-51. [Serebriakov VG, Alekberova ZS, Koreshkov GG, Zenovko EI. The characteristics of the course of rheumatoid arthritis combined with thyroid pathology. Terapevticheskii arkhiv = Therapeutic Archive. 1990;62(5):48-51 (In Russ.)].
56. Koszarny A, Majdan M, Suszek D, et al. Relationship between rheumatoid arthritis activity and antithyroid antibodies. Pol Arch Med Wewn. 2013;123(7-8):394-400.
57. Raterman HG, Voskuyl AE, Simsek S, et al. Increased progression of carotid intima media thickness in thyroid peroxidase antibodies-positive rheumatoid arthritis patients. Eur J Endocrinol. 2013 Oct 21;169(6):751-7. doi: 10.1530/EJE-13-0394
58. Dessein PH, Joffe BI, Stanwix AE. Subclinical hypothyroidism is associated with insulin resistance in rheumatoid arthritis. Thyroid. 2004 Jun;14(6):443-6. doi: 10.1089/105072504323150750
59. Raterman HG, van Eijk IC, Voskuyl AE, et al. The metabolic syndrome is amplified in hypothyroid rheumatoid arthritis patients: a cross-sectional study. Ann Rheum Dis. 2010 Jan;69(1):39-42. doi: 10.1136/ard.2008.100776
60. Dessein PH, Joffe BI, Veller MG, et al. Traditional and nontraditional cardiovascular risk factors are associated with atherosclerosis in rheumatoid arthritis. J Rheumatol. 2005 Mar;32(3):435-42.
61. Dessein PH, Norton GR, Woodiwiss AJ, et al. Influence of nonclassical cardiovascular risk factors on the accuracy of predicting subclinical atherosclerosis in rheumatoid arthritis. J Rheumatol. 2007 May;34(5):943-51.
62. Marchiori RC, Pereira LA, Naujorks AA, et al. Improvement of blood inflammatory marker levels in patients with hypothyroidism under levothyroxine treatment. BMC Endocr Disord. 2015 Jun 23;15:32. doi: 10.1186/s12902-015-0032-3
Review
For citations:
Kondratyeva L.V., Popkova T.V. AUTOIMMUNE DISEASES AND THYROID DYSFUNCTION IN RHEUMATOID ARTHRITIS. Rheumatology Science and Practice. 2017;55(2):211-217. (In Russ.) https://doi.org/10.14412/1995-4484-2017-211-217
Views:
4706
Email this article 